Alabama · 0241U

Respiratory Infectious Agent Detection By Rna For Severe Acute Respiratory Syndrome Coronavirus 2 (covid 19), Influenza A, Influenza B, And Respiratory Syncytial Virus, Upper Respiratory Specimen, Each Reported As Detected Or Not Detected in Alabama

Alabama Medicare Avg
$136.01
2% below national avg
National Medicare Avg
$138.72
All states combined
Billed Charge (AL)
$229.02
What providers submit
Est. Commercial (AL)
$299.23
National avg: $310.72
Est. Cash / Self-Pay (AL)
$164.99
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

5.8K
Services in AL
352
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Alabama

Provider Medicare Services
Decatur Diagnostic Laboratory, Inc. $125.95 496
Oyler, Richard MD $139.78 313
Microphase Clinical Laboratory $139.78 220
Golden Point Solutions Llc $137.55 188
O'mara, Sean M.D. $138.64 116
Ismail, Younus M.D. $134.33 77
Coefield, Melissa NURSE PRACTITIONER $134.42 74
Uptagrafft, Brooke M.D. $139.78 58
Diaz, Kelly MD $139.78 58
Tuten, John MD $132.24 55
O'halloran, Christopher D.O. $139.78 46
Showers, David M.D. $139.78 44

Alabama Pricing in Context

In Alabama, CPT code 0241U (Respiratory Infectious Agent Detection By Rna For Severe Acute Respiratory Syndrome Coronavirus 2 (covid 19), Influenza A, Influenza B, And Respiratory Syncytial Virus, Upper Respiratory Specimen, Each Reported As Detected Or Not Detected) carries an average Medicare payment of $136.01 — 2% below the national benchmark of $138.72. 352 providers across the state submitted claims for this procedure in 2023, performing 5.8K total services. Individual payments in AL ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Alabama is $229.02, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Alabama sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Vaccines & Injections procedures, the estimated commercial insurance price in Alabama lands near $299.23, with self-pay cash prices typically around $164.99. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Respiratory Infectious Agent Detection By Rna For Severe Acute Respiratory Syndrome Coronavirus 2 (covid 19), Influenza A, Influenza B, And Respiratory Syncytial Virus, Upper Respiratory Specimen, Each Reported As Detected Or Not Detected cost in Alabama?

The average Medicare payment for Respiratory Infectious Agent Detection By Rna For Severe Acute Respiratory Syndrome Coronavirus 2 (covid 19), Influenza A, Influenza B, And Respiratory Syncytial Virus, Upper Respiratory Specimen, Each Reported As Detected Or Not Detected in Alabama is $136.01, which is 2% below the national average of $138.72. Providers in AL typically bill $229.02 for this procedure.

What does Respiratory Infectious Agent Detection By Rna For Severe Acute Respiratory Syndrome Coronavirus 2 (covid 19), Influenza A, Influenza B, And Respiratory Syncytial Virus, Upper Respiratory Specimen, Each Reported As Detected Or Not Detected cost with insurance in Alabama?

With commercial insurance in Alabama, Respiratory Infectious Agent Detection By Rna For Severe Acute Respiratory Syndrome Coronavirus 2 (covid 19), Influenza A, Influenza B, And Respiratory Syncytial Virus, Upper Respiratory Specimen, Each Reported As Detected Or Not Detected costs an estimated $299.23. Without insurance, the estimated cash price is $164.99. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Respiratory Infectious Agent Detection By Rna For Severe Acute Respiratory Syndrome Coronavirus 2 (covid 19), Influenza A, Influenza B, And Respiratory Syncytial Virus, Upper Respiratory Specimen, Each Reported As Detected Or Not Detected in Alabama?

352 providers in Alabama billed Medicare for Respiratory Infectious Agent Detection By Rna For Severe Acute Respiratory Syndrome Coronavirus 2 (covid 19), Influenza A, Influenza B, And Respiratory Syncytial Virus, Upper Respiratory Specimen, Each Reported As Detected Or Not Detected in 2023, performing 5.8K total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Respiratory Infectious Agent Detection By Rna For Severe Acute Respiratory Syndrome Coronavirus 2 (covid 19), Influenza A, Influenza B, And Respiratory Syncytial Virus, Upper Respiratory Specimen, Each Reported As Detected Or Not Detected cheaper in Alabama than the national average?

Yes — Respiratory Infectious Agent Detection By Rna For Severe Acute Respiratory Syndrome Coronavirus 2 (covid 19), Influenza A, Influenza B, And Respiratory Syncytial Virus, Upper Respiratory Specimen, Each Reported As Detected Or Not Detected costs 2% below the national average in Alabama. The state average Medicare payment is $136.01 compared to $138.72 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial